An independent NIH panel has recommended the continued use of the current two-step method in diagnosing gestational diabetes in U.S. women, as more studies may be needed to consider a one-step approach proposed by the International Association of the Diabetes and Pregnancy Study Groups. "The panel is particularly concerned about the adoption of new criteria that would increase the prevalence of GDM, and the corresponding costs and interventions, without clear demonstration of improvements in the most clinically important health and patient-centered outcomes," the panel said.
NIH still recommends 2-step method in detecting GDM
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan